Portola Pharmaceuticals

E852346

Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.

All labels observed (1)

Label Occurrences
Portola Pharmaceuticals canonical 3

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf biopharmaceutical company ⓘ
acquiredBy Alexion Pharmaceuticals ⓘ
acquisitionYear 2020 ⓘ
activeIngredientOf andexanet alfa ⓘ
betrixaban ⓘ
brandNameOf Andexxa ⓘ
Bevyxxa ⓘ
Ondexxya ⓘ
country United States ⓘ
developed andexanet alfa ⓘ
betrixaban ⓘ
developedFor prevention of venous thromboembolism ⓘ
reversal of factor Xa inhibitor anticoagulation ⓘ
focusesOn anticoagulant reversal agents ⓘ
factor Xa inhibitors ⓘ
hospital-based therapies ⓘ
hasAbbreviation Portola ⓘ
hasDrugClass anticoagulant reversal agent ⓘ
direct oral anticoagulant ⓘ
hasTherapyType recombinant proteins ⓘ
small molecule drugs ⓘ
headquartersLocation South San Francisco, California ⓘ
linked to: South San Francisco
industry biotechnology ⓘ
pharmaceuticals ⓘ
listedOn NASDAQ ⓘ
market hospital acute care ⓘ
pipelineFocus hematologic disorders ⓘ
thrombosis prevention ⓘ
product Andexxa ⓘ
Bevyxxa ⓘ
Ondexxya ⓘ
regionServed global ⓘ
regulatoryApproval Andexxa FDA approval ⓘ
Bevyxxa FDA approval ⓘ
regulatoryRegion European Union ⓘ
United States ⓘ
researchArea coagulation pathways ⓘ
factor Xa biology ⓘ
thrombotic disorders ⓘ
specializesIn hematologic conditions ⓘ
thrombosis therapies ⓘ
targetPatientGroup patients at risk of venous thromboembolism ⓘ
patients on factor Xa inhibitors ⓘ
therapeuticArea cardiovascular disease ⓘ
hematology ⓘ
thromboembolism ⓘ

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

andexanet alfa → developedBy → Portola Pharmaceuticals ⓘ
Andexxa → hasManufacturer → Portola Pharmaceuticals ⓘ
Ondexxya → developedBy → Portola Pharmaceuticals ⓘ